Sildenafil before liver surgery
Treatments studied
This trial tests if taking sildenafil before liver surgery helps patients. It is for people having a partial liver removal who are in fairly good health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for liver surgery (partial removal of the liver).
- You are between 18 and 85 years old.
- Your liver function is still good (Child-Pugh score A or B).
- You have a low to moderate anesthesia risk (ASA class II or III).
- You are not pregnant or breastfeeding, and have no allergies to the study drugs.
- Your blood counts, kidney function, blood pressure, and weight are within safe ranges.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how the drugs sildenafil and pravastatin work in people with a single ventricle heart condition who have had the Fontan surgery and may have related liver problems. The goal is to find the best doses based on liver function.
This trial tests if sildenafil can help people with severe pulmonary hypertension caused by rheumatic valvular heart disease. It aims to see if the drug improves symptoms and heart function.
This trial studies whether sildenafil (a medicine that helps relax blood vessels) can improve outcomes in babies born with a congenital diaphragmatic hernia (CDH) after they’ve had surgery. Babies are selected based on an ultrasound/echo of heart function after repair.
This trial tests whether sildenafil (the drug in Viagra) can help reduce blood vessel changes in people with a left ventricular assist device (LVAD). It aims to improve heart-pump function and overall health.
This trial tests whether a medication called vericiguat, given around the time of heart surgery, can help protect your heart and prevent heart failure complications. You'll receive the study drug or a placebo before and after surgery and be monitored for 6 months.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
Hear when a new Hepatectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.